Summary The coronavirus (COVID-19) company impact report analyses how the pandemic will impact Best Buy’s performance.
Best Buy’s group sales are forecast to decline by 2.7% in 2020, driven by the closure of its store portfolio in the height of the COVID 19 pandemic.
Best Buy’s response to the pandemic has been strong, with the retailer placing a focus not just on sales but on its customers and staff.
Scope - Geographically , Best Buy is exposed to the difficulties caused by the COVID-19 pandemic due to its reliance on North America which has been the region most affected by the virus.
- With Best Buy now beginning to open some of its stores, with an online scheduling process in place and strict guidelines, Best Buy will be able to entice some spend through its branches over the coming months.
- Best Buy has partnered with two Minnesota organizations to provide Chromebooks and laptops to teens in need to help ensure they can continue their studies at home.
Reasons to Buy - Use our revised 2020 forecast for Best Buy to understand how the COVID-19 pandemic will impact its performance this year.
- Use our charts to review how Best Buy’s sales are split by region globally and how these regions have been impacted by COVID-19.
- Use our in-depth analysis to review how Best Buy has responded to COVID-19 and how this will affect its performance.
Our reports have been used by over 10K customers, including:
The frozen tissues samples market is projected to reach US$ 105,045.91 Thousand by 2028 from US$ 44,399.07 Thousand in 2021; it is estimated to grow at a CAGR of 13.1% during 2021-2028. The report highlights trends prevailing in the market and the factors driving it.The growth of the frozen tissues samples market is attributed to the...
The global immunoglobulin market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...
200 pages •
By The Business Research Company
• May 2022
Major players in the anatomical pathology equipment and consumables market are Epridea, F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific, Sakura Finetek, Agilent Technologies, Danaher Corporation, Bio SB, BioGenex Laboratories, and Quest Diagnostics Incorporated. The global anatomic pathology equipment and consumables...
175 pages •
By The Business Research Company
• May 2022
Major players in the critical illness market are China Life Insurance, Allianz, Ping An Insurance, Aviva, Legal & General, China Pacific Insurance, Prudential plc, New China Life Insurance, Aegon, and AXA. The global critical illness insurance market is expected to grow from $185.53 billion in 2021 to $215.49 billion in 2022 at a compound...
The global alopecia treatment market reached a value of US$ 3 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 3.9 Billion by 2027, exhibiting a CAGR of 4.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as...
Deep brain stimulation (DBS) therapies target a growing number of existing indications, including movement disorders and neuropsychiatric conditions, and newer areas such as lifestyle disorders, including diabetes and obesity.This will allow more patients to benefit from the therapy. According to the WHO, neurological diseases currently...
The global intravenous solutions market reached a value of US$ 13.2 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 18.6 Billion by 2027, exhibiting a CAGR of 5.96% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...
The global surrogacy market reached a value of US$ 161.83 Million in 2021. Looking forward, the analyst expects the market to reach a value of US$ 240.56 Million by 2027, exhibiting a CAGR of 6.62% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...
Non Alcoholic Fatty Liver Disease (NAFLD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Non Alcoholic Fatty Liver Disease (NAFLD) - Drugs in Development by Stages, Target, MoA,...
Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Janus kinase 2 is a non-receptor tyrosine...
Pathology
Pharmaceutical
Biopharmaceutical
World
China
Japan
Stem Cell Transplantation
Drug Approval
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.